These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 6439116)
21. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa. Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812 [TBL] [Abstract][Full Text] [Related]
22. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates. Bassey CM; Baltch AL; Smith RP J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401 [TBL] [Abstract][Full Text] [Related]
23. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Scribner RK; Marks MI; Weber AH; Tarpay MM; Welch DF Antimicrob Agents Chemother; 1982 Jun; 21(6):939-43. PubMed ID: 6810757 [TBL] [Abstract][Full Text] [Related]
24. Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents. Davidson S; Lipshitz M; Bogokowski B; Rubinstein E Isr J Med Sci; 1982 Aug; 18(8):859-62. PubMed ID: 6811501 [TBL] [Abstract][Full Text] [Related]
25. The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa. Rolston KV; Chandrasekar PH; LeFrock JL; Schell RF Chemotherapy; 1984; 30(1):31-4. PubMed ID: 6420119 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of enoxacin compared with norfloxacin and amikacin. van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568 [TBL] [Abstract][Full Text] [Related]
27. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa. Gerçeker AA; Otük G Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
29. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa]. Cluzel M; Chanal M; Sirot J; Cluzel R Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new. Korvick J; Yu VL; Hilf M Diagn Microbiol Infect Dis; 1987 Jun; 7(2):107-11. PubMed ID: 3115670 [TBL] [Abstract][Full Text] [Related]
31. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests. Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985 [TBL] [Abstract][Full Text] [Related]
32. In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa. Pfaller M; Bale M; Preston T; Howard W; Koontz F Diagn Microbiol Infect Dis; 1986 May; 5(1):17-23. PubMed ID: 3086026 [TBL] [Abstract][Full Text] [Related]
33. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa. Bert F; Bruneau B; Lambert-Zechovsky N; Branger C Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936 [TBL] [Abstract][Full Text] [Related]
34. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp. Baltch AL; Smith RP; Ritz W Chemotherapy; 1994; 40(6):391-8. PubMed ID: 7842822 [TBL] [Abstract][Full Text] [Related]
35. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa. Stratton CW; Weeks LS; Tausk F J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276 [TBL] [Abstract][Full Text] [Related]
36. Susceptibility of Pseudomonas aeruginosa strains isolated from hospitalized children. Patzer J; Walkiewicz R; Dzierzanowska D J Antimicrob Chemother; 1986 Jul; 18(1):45-9. PubMed ID: 3093444 [TBL] [Abstract][Full Text] [Related]
37. Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Prince AS; Neu HC Antimicrob Agents Chemother; 1981 Oct; 20(4):545-6. PubMed ID: 6282199 [TBL] [Abstract][Full Text] [Related]
38. In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa. Meyer RD; Liu S Diagn Microbiol Infect Dis; 1988 Nov; 11(3):151-7. PubMed ID: 3149927 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates of Pseudomonas aeruginosa. Vurma-Rapp U; Kayser FH Eur J Clin Microbiol; 1986 Jun; 5(3):292-6. PubMed ID: 3091365 [TBL] [Abstract][Full Text] [Related]
40. In-vitro activity of ciprofloxacin and other beta-lactam antibiotics against gentamicin- and carbenicillin-resistant isolates of Pseudomonas aeruginosa. Sofianou DC; Douboyas JP J Chemother; 1991 Feb; 3(1):3-5. PubMed ID: 1902252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]